Substituted 8-heteroaryl xanthines

Details Substituted 8-heteroaryl xanthines Substituted 8-heteroaryl xanthines

2007-12-14

2010-06-08

Berch, Mark L (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S263210, C514S263220, C544S269000, C544S270000

Reexamination Certificate

active

07732455

ABSTRACT:
Selective antagonists of A2Badenosine receptors like those of formula I are provided.These compounds and compositions are useful as pharmaceutical agents.

REFERENCES:
patent: 6060481 (2000-05-01), LaNoue et al.
patent: 6770267 (2004-08-01), Daluge et al.
patent: 6825349 (2004-11-01), Kalla et al.
patent: 6894021 (2005-05-01), Belardinelli et al.
patent: 6977300 (2005-12-01), Kalla et al.
patent: 7205403 (2007-04-01), Baraldi et al.
patent: 7304070 (2007-12-01), Kalla et al.
patent: 7342006 (2008-03-01), Wang et al.
patent: 7579348 (2009-08-01), Wang et al.
patent: 7598379 (2009-10-01), Wang et al.
patent: 7601723 (2009-10-01), Wang et al.
patent: 7618962 (2009-11-01), Wang et al.
patent: 7625881 (2009-12-01), Kalla et al.
patent: 2004/0192708 (2004-09-01), Dunten et al.
patent: 2006/0058322 (2006-03-01), Zeng et al.
patent: 2006/0159627 (2006-07-01), Zeng et al.
patent: 2007/0219221 (2007-09-01), Zeng et al.
patent: 2008/0004292 (2008-01-01), Wang et al.
patent: 2008/0045549 (2008-02-01), Baraldi et al.
patent: 2008/0200456 (2008-08-01), Wang et al.
patent: 2009/0163491 (2009-06-01), Thompson et al.
patent: 2009/0298744 (2009-12-01), Palle et al.
patent: WO 03/042214 (2003-05-01), None
patent: WO 03/063800 (2003-08-01), None
patent: 2006028810 (2006-03-01), None
Sekine et al., Chemical and pharmaceutical bulletin 1989, vol. 37, No. 8, pp. 1987-1989.
I.I. Kuz'Menko, et al., “Reactions of Theophyllines. Chemical Conversions of 8-Aminotheophyllinates”, Chemistry of Heterocyclic Compounds, 2000, pp. 963-970, vol. 36, No. 8.
Database Caplus [Online] “Dimerizations of .pi—rich N-heteroaromatic compounds and xanthine derivatives”, Chemical and Pharmaceutical Bulletin, vol. 37, No. 8 1989, pp. 1987-1989; Chemical Abstracts Services, Columbus, Ohio, US; XP002319750.
Scammells, et al., “Substituted 1,3 Dipropylxanthines as Irreversible Antagonists of A1 Adenosine Receptors”, J. Med. Chem. 1994, 37, 2704-2712.
PCT/US04/27133 International Preliminary Examination Report (corresponding PCT application).
PCT/US04/27133 Written Opinion (corresponding PCT application).

Affiliated with

Also associated with

Rating

Substituted 8-heteroaryl xanthines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 8-heteroaryl xanthines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 8-heteroaryl xanthines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4208873